Anti-TPO Positive but TSH Normal: What It Means

01

What anti-TPO actually measures

Thyroid peroxidase is the enzyme the thyroid uses to build its hormones. Anti-TPO is an antibody your own immune system has made against that enzyme, and measuring it, in the American Thyroid Association's words, may help diagnose the cause of a thyroid problem. It is the marker of autoimmune thyroiditis: StatPearls reports thyroid peroxidase antibody in over 90 percent of individuals with Hashimoto thyroiditis. So a positive result names a mechanism. It does not, by itself, name a disease you have today.

It is also common in people who are perfectly well. In the NHANES III survey, 14.6 percent of euthyroid women and 8.0 percent of euthyroid men had such antibodies. StatPearls puts thyroid antibody positivity at roughly 10 percent of the US population, with published estimates in the general population ranging from 5 to 20 percent, and gives global Hashimoto prevalence as 7.5 percent, higher at 11.4 percent in low- and middle-income areas, with prevalence in women about four times that in men.

What the test does not do is measure thyroid function. That is the job of TSH, with free T4 alongside it. One more point of confusion is worth clearing: thyroglobulin antibody is a different antibody from thyroglobulin itself. The American Thyroid Association describes thyroglobulin as a protein made by normal and by cancerous thyroid cells, used most often to monitor people after surgery for thyroid cancer, and states that it is not a measure of thyroid function.

02

My TSH is normal and anti-TPO is high — am I hypothyroid?

No. Hypothyroidism is defined by hormone levels, not by antibodies, and a TSH inside the reference range means the gland is currently producing what your body is asking for. StatPearls notes that about 20 to 30 percent of individuals with Hashimoto thyroiditis develop hypothyroidism, which is another way of saying that most people with the autoimmune process do not, at least not over the period studied. A positive antibody with normal function is a starting position, not a delayed diagnosis.

This matters because the temptation, once the word antibody appears, is to hang every symptom on it. Tiredness, weight change and hair thinning are common in the general population and common in people with normal thyroid function. A review in Clinical Medicine and Research is blunt about the cost of the label, warning of the possible adverse psychological effect of a positive anti-TPO result and arguing that the test should be discouraged in the assessment of subclinical hypothyroidism and should never be performed when the TSH is normal, except in circumstances involving pregnancy.

If you already have the result, it is not wasted. It explains a raised TSH if one ever appears, it predicts what happens after childbirth, and it changes decisions during pregnancy. What it does not do is convert a normal thyroid test into a condition that needs treating. Our story on thyroid function and tiredness goes into the symptom question, which is a separate one from the antibody question.

03

How high is high, and does 600 mean worse than 90?

The result is meant to be read as positive or negative against your own laboratory's cut-off, and that is the form in which every guideline statement about it is written. Recommendations say TPO antibody positive or TPO antibody negative. None of them sets a treatment threshold at a particular antibody value, and none distinguishes a result just over the limit from one many times higher. A value of 600 and a value of 90 are both, for the purposes of what happens next, a positive result.

So the decisions are made elsewhere. Whether you need levothyroxine is decided by TSH and free T4, which the American Thyroid Association describes as the tests that show how the gland is functioning. When thyroid function is normal, a very high titre and a barely positive one lead to the same next step: a thyroid function test in about a year, and no medicine in the meantime. Nothing about the size of the number shortens that interval on its own. None of that is about stopping anything: if you are already taking levothyroxine, a normal TSH means the dose is doing its job, and whether to change or stop it is your prescriber's decision rather than something an antibody result settles.

Where the number does earn its place is in diagnosis. Because over 90 percent of people with Hashimoto thyroiditis have TPO antibodies, a positive result sitting alongside a genuinely raised TSH points to autoimmune thyroiditis as the cause rather than to something else, which is useful information for the person managing you. That is a one-off contribution, made the first time the test is run.

04

What are the real odds I will need thyroid medicine later?

The most-cited long-term figures come from the twenty-year follow-up of the Whickham survey, summarised in the Clinical Medicine and Research review: the risk of developing hypothyroidism ran at about 2.1 percent per year on the basis of positive anti-TPO antibodies alone with a normal TSH, and at about 4.3 percent per year where a TSH above 6.0 was combined with positive antibodies. The two findings together roughly double the yearly rate seen with the antibody alone, which is why a TSH that has already begun to drift upward tells you more than the antibody value does.

Sources word this differently and it is worth seeing both. StatPearls states that the risk of developing hypothyroidism increases by 5 percent every year in people with Hashimoto thyroiditis, a group already selected for having the diagnosis, while the Whickham figure describes ordinary antibody-positive people in the community whose thyroid function was normal at the start. The two numbers are measuring different populations rather than contradicting each other, and both describe a gradual drift rather than an approaching event.

Translated into ordinary terms, a yearly risk of around 2 percent means most antibody-positive people with a normal TSH will still have a normal TSH several years from now, and a minority will not. That is exactly the kind of risk a once-a-year blood test handles well and that daily medicine handles badly. It is also why no guideline recommends starting levothyroxine on the strength of an antibody result while thyroid function is normal.

05

How often should I retest, and which test?

TSH is the test. The American Thyroid Association states that the best way to initially test thyroid function is to measure the TSH level in a blood sample, and that a free T4 or free T4 index more accurately reflects how the thyroid is functioning when checked together with a TSH. T3 testing is the one most often added unnecessarily: the same source notes that T3 tests are useful in diagnosing hyperthyroidism or judging its severity, but that T3 testing rarely is helpful in the hypothyroid patient.

On frequency, StatPearls states that individuals with Hashimoto thyroiditis should undergo annual thyroid function testing. Sooner is reasonable if something changes — new and persistent tiredness, cold intolerance, constipation and slowed thinking together, a visibly enlarging neck, or a pregnancy, planned or discovered. Outside those situations, testing every few months tends to generate borderline results that get chased rather than information that changes anything.

One practical point about interpreting a result that sits just outside the range: the decision to treat rests on TSH and free T4 together, so ask what the free T4 showed before anything is started, and expect a borderline TSH to be repeated rather than acted on immediately. The antibody result does not need to be part of that conversation at all, for the reasons the next section sets out.

06

Does a positive anti-TPO change anything in pregnancy?

Pregnancy is the one setting where the antibody result genuinely changes the treatment decision, and it is the exception the Clinical Medicine and Research review itself carves out. Our guide to TSH in pregnancy sets out the thresholds in full and is the place to go if you are holding a pregnancy thyroid report. In short, under the 2017 American Thyroid Association guidance, levothyroxine is recommended for TPOAb-positive women whose TSH is above the pregnancy-specific reference range, and is only something that may be considered lower down that scale.

The reason is an association with outcomes. A review of those guidelines reports a significant increase in miscarriage in women with TPO antibodies compared with those without, and that thyroid autoantibody positivity is associated with increased risk for preterm delivery. Association is the correct word: these studies show the two things occur together, not that the antibody causes the loss, and the distinction turns out to matter a great deal for what treatment can be expected to achieve.

That is because treating the antibody has been tested directly and did not help. The TABLET trial randomised 952 euthyroid women with thyroid peroxidase antibodies who were trying to conceive to levothyroxine or placebo. Live birth was 37 percent, 176 of 470, with levothyroxine and 38 percent, 178 of 470, with placebo, a relative risk of 0.97 with a confidence interval from 0.83 to 1.14. Miscarriage, 28 against 30 percent, and preterm birth, 15 against 18 percent, showed no significant difference either.

The year after the birth is the other place this result earns its keep. StatPearls describes postpartum thyroiditis as usually developing around six months after childbirth, though it can appear at any point in the first year, and as mostly seen in women who already have underlying Hashimoto thyroiditis; it is usually temporary, although a few women are left with permanent hypothyroidism. So if you are antibody-positive and have recently given birth, new exhaustion, palpitations or low mood during that first year is a reason to ask for a thyroid function test rather than a reason to wait for the annual one.

07

Should I repeat the antibody test to watch it fall?

No, and this is the clearest single statement in the guidance. On thyroid antibody tests, the American Thyroid Association says directly that following their levels over time is not helpful in detecting the development of hypothyroidism or response to therapy. The number is not a disease-activity score. It does not tell you how much working gland is left, it does not track how you feel, and it does not move in a way that predicts when or whether you will need treatment.

The association makes an instructive exception for a different antibody. In Graves disease, following levels of the stimulatory TSH receptor antibody may help to assess response to treatment of an overactive thyroid and to determine when it is appropriate to stop antithyroid medicine. That is what a useful monitoring test looks like: the result changes a decision. Anti-TPO in someone with a normal TSH changes none, whichever direction it moves.

So if a repeat anti-TPO is offered as monitoring, the fair question is what a higher or lower result would change. If the answer is nothing, the test is measuring your anxiety rather than your thyroid, and the money is better spent on the annual TSH that guidance actually asks for. The same logic applies to any product or programme that offers to bring the antibody number down, which is where the next section starts.

08

Selenium, gluten and iodine: what the evidence shows

Selenium is the supplement most often suggested, and the Cochrane review of it is worth quoting rather than paraphrasing. Four randomised trials, 463 participants, mean duration 7.5 months. Selenium reduced anti-thyroid peroxidase antibody levels compared with placebo in three of them, but the reviewers note that although the changes from baseline were statistically significant, their clinical relevance is unclear, and conclude that the evidence to support or refute the efficacy of selenium supplementation in people with Hashimoto thyroiditis is incomplete.

Read that alongside the previous section and the shape of the problem is clear: the trials moved the number that guidance says not to follow, and the outcomes people actually care about were not measured — change in health-related quality of life was not assessed in any of the studies. In pregnancy the position is firmer still. The 2017 American Thyroid Association guidance is that selenium supplementation should not be recommended for the treatment of TPOAb-positive women during pregnancy.

On diet, StatPearls states that limited evidence supports the benefits of an autoimmune or anti-inflammatory diet, and describes a small study of 40 women that found improvements in thyroid function and lower thyroid peroxidase and thyroglobulin antibody levels on a Mediterranean, gluten-free diet — one small study, and a thin basis for a lifelong restriction. Iodine deserves particular caution: the same source notes that many people in iodine-sufficient areas take iodine supplements for thyroid health, and that excess iodine supplementation tends to worsen Hashimoto thyroiditis.